BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6218942)

  • 1. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.
    Wiman B; Mellbring G; Rånby M
    Clin Chim Acta; 1983 Jan; 127(2):279-88. PubMed ID: 6218942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharose.
    Gyzander E; Eriksson E; Teger-Nilsson AC
    Thromb Res; 1984 Sep; 35(5):547-58. PubMed ID: 6541374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaustion of arm fibrinolytic potential after repeated venous occlusions and local exercise.
    Keber D; Stegnar M
    Thromb Res; 1982 Dec; 28(6):693-704. PubMed ID: 6891973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
    Gonias SL; Einarsson M; Pizzo SV
    J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.
    Levin RI; Harpel PC; Weil D; Chang TS; Rifkin DB
    J Clin Invest; 1984 Aug; 74(2):571-80. PubMed ID: 6235245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colorimetric assay for releasable plasminogen activator.
    Campbell EE; Shifman MA; Lewis JG; Pasqua JJ; Pizzo SV
    Clin Chem; 1982 May; 28(5):1125-8. PubMed ID: 6210467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of venous stasis on plasminogen activation and plasma alpha 2-antiplasmin levels in type II diabetes mellitus].
    Longoni P; Montani N; Gangale MG; Gamba G
    Recenti Prog Med; 1987; 78(7-8):323-7. PubMed ID: 3423401
    [No Abstract]   [Full Text] [Related]  

  • 12. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease.
    Bergsdorf N; Nilsson T; Wallén P
    Thromb Haemost; 1983 Oct; 50(3):740-4. PubMed ID: 6359572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of local exercise and vessel occlusion on fibrinolytic activity.
    Rennie JA; Bennett B; Ogston D
    J Clin Pathol; 1977 Apr; 30(4):350-2. PubMed ID: 856879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plasmin generation method for the determination of tissue plasminogen activator (t-PA) activity in blood.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():197-203. PubMed ID: 2529206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
    Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
    Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of tissue plasminogen activator in plasma samples by means of a radioimmunoassay.
    Urdén G; Blombäck M
    Scand J Clin Lab Invest; 1984 Oct; 44(6):495-502. PubMed ID: 6541367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.